Bajin Wei

1.4k total citations
32 papers, 832 citations indexed

About

Bajin Wei is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Bajin Wei has authored 32 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Bajin Wei's work include RNA modifications and cancer (7 papers), Ubiquitin and proteasome pathways (6 papers) and Epigenetics and DNA Methylation (4 papers). Bajin Wei is often cited by papers focused on RNA modifications and cancer (7 papers), Ubiquitin and proteasome pathways (6 papers) and Epigenetics and DNA Methylation (4 papers). Bajin Wei collaborates with scholars based in China, United States and Madagascar. Bajin Wei's co-authors include Chunyang Xing, Peifen Fu, Minya Yao, Yu Liu, Zhijun Dai, Haiyang Xie, Yujiao Deng, Shuqian Wang, Shusen Zheng and Lin Zhou and has published in prestigious journals such as Molecular Cell, Biochemical and Biophysical Research Communications and Theranostics.

In The Last Decade

Bajin Wei

30 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bajin Wei China 15 357 324 202 127 99 32 832
Jens Voortman Netherlands 19 358 1.0× 427 1.3× 151 0.7× 157 1.2× 110 1.1× 41 890
Ahmad Shariftabrizi United States 18 308 0.9× 308 1.0× 173 0.9× 194 1.5× 79 0.8× 44 866
Domenico Sergi Italy 16 359 1.0× 178 0.5× 157 0.8× 166 1.3× 77 0.8× 54 796
Rafał Stec Poland 18 445 1.2× 377 1.2× 211 1.0× 303 2.4× 54 0.5× 61 926
Yingying Hao China 18 174 0.5× 504 1.6× 209 1.0× 103 0.8× 242 2.4× 48 874
Qiongrong Chen China 12 390 1.1× 419 1.3× 119 0.6× 84 0.7× 42 0.4× 30 905
Fei Lian United States 16 192 0.5× 336 1.0× 163 0.8× 214 1.7× 58 0.6× 33 672
Alaa Abduljabbar Saudi Arabia 14 397 1.1× 409 1.3× 191 0.9× 139 1.1× 39 0.4× 33 850
Philip E. Lammers United States 18 374 1.0× 198 0.6× 116 0.6× 149 1.2× 167 1.7× 40 743
Morikazu Miyamoto Japan 16 209 0.6× 249 0.8× 140 0.7× 88 0.7× 80 0.8× 82 857

Countries citing papers authored by Bajin Wei

Since Specialization
Citations

This map shows the geographic impact of Bajin Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bajin Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bajin Wei more than expected).

Fields of papers citing papers by Bajin Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bajin Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bajin Wei. The network helps show where Bajin Wei may publish in the future.

Co-authorship network of co-authors of Bajin Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Bajin Wei. A scholar is included among the top collaborators of Bajin Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bajin Wei. Bajin Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Guansheng, et al.. (2024). CPSF4-mediated regulation of alternative splicing of HMG20B facilitates the progression of triple-negative breast cancer. Journal of Translational Medicine. 22(1). 1149–1149.
2.
Wei, Bajin, Fan Yang, Luyang Yu, & Cong Qiu. (2024). Crosstalk between SUMOylation and other post-translational modifications in breast cancer. Cellular & Molecular Biology Letters. 29(1). 8 indexed citations
3.
Zhang, Zhijun, Bajin Wei, Zhikun Liu, et al.. (2024). Nomogram for prediction of hepatocellular carcinoma recurrence after liver resection. Hepatobiliary & pancreatic diseases international. 24(3). 269–276.
4.
5.
6.
Wu, Ying, Yujiao Deng, Bajin Wei, et al.. (2022). Global, regional, and national childhood cancer burden, 1990–2019: An analysis based on the Global Burden of Disease Study 2019. Journal of Advanced Research. 40. 233–247. 68 indexed citations
7.
Li, Yizhen, Jinxin Zheng, Yujiao Deng, et al.. (2022). Global Burden of Female Breast Cancer: Age-Period-Cohort Analysis of Incidence Trends From 1990 to 2019 and Forecasts for 2035. Frontiers in Oncology. 12. 891824–891824. 35 indexed citations
8.
Deng, Yujiao, Meng Wang, Peng Xu, et al.. (2022). Effects of Antihypertensive Drugs Use on Risk and Prognosis of Colorectal Cancer: A Meta-Analysis of 37 Observational Studies. Frontiers in Pharmacology. 12. 670657–670657. 6 indexed citations
9.
Zhang, Dai, Yi Zheng, Si Yang, et al.. (2021). Identification of a Novel Glycolysis-Related Gene Signature for Predicting Breast Cancer Survival. Frontiers in Oncology. 10. 596087–596087. 21 indexed citations
10.
Deng, Yujiao, Bajin Wei, Zhen Zhai, et al.. (2021). Dietary Risk-Related Colorectal Cancer Burden: Estimates From 1990 to 2019. Frontiers in Nutrition. 8. 690663–690663. 48 indexed citations
11.
Yao, Minya, Shuqian Wang, Luyan Chen, Bajin Wei, & Peifen Fu. (2021). Research on correlations of miR-585 expression with progression and prognosis of triple-negative breast cancer. Clinical and Experimental Medicine. 22(2). 201–207. 11 indexed citations
12.
Bi, Yanli, Xiaoyu Chen, Bajin Wei, et al.. (2021). DEPTOR stabilizes ErbB2 to promote the proliferation and survival of ErbB2-positive breast cancer cells. Theranostics. 11(13). 6355–6369. 12 indexed citations
13.
Zhang, Zhengkui, Shuai Wang, Li Shao, et al.. (2018). OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ. Molecular Cell. 73(1). 7–21.e7. 141 indexed citations
14.
Wei, Bajin, Minya Yao, Chunyang Xing, et al.. (2016). The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis. OncoTargets and Therapy. Volume 9. 5567–5575. 116 indexed citations
15.
Xie, Haiyang, Chunyang Xing, Bajin Wei, et al.. (2015). Polymorphisms of FGFR1 in HBV-related hepatocellular carcinoma. Tumor Biology. 36(11). 8881–8886. 1 indexed citations
16.
Fu, Peifen, Minya Yao, Yu Liu, et al.. (2014). Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer. OncoTargets and Therapy. 7. 1743–1743. 75 indexed citations
17.
Wu, Liming, Lin Zhou, Jun Xu, et al.. (2013). Lack of association between genetic polymorphisms in cytokine genes and tumor recurrence in patients with hepatocellular carcinoma undergoing transplantation. Hepatobiliary & pancreatic diseases international. 12(1). 54–59. 11 indexed citations
18.
Xing, Chunyang, Wuhua Zhou, Songming Ding, et al.. (2012). Reversing Effect of Ring Finger Protein 43 Inhibition on Malignant Phenotypes of human Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 12(1). 94–103. 23 indexed citations
19.
Xing, Chunyang, Haiyang Xie, Lin Zhou, et al.. (2012). Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation. Biochemical and Biophysical Research Communications. 420(1). 29–35. 46 indexed citations
20.
Wu, Liming, Lin Chen, Lin Zhou, et al.. (2011). Association of interleukin 18 gene promoter polymorphisms with HBV recurrence after liver transplantation in Han Chinese population.. PubMed. 11(6). 469–74. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jens Voortman Breakdown of academic impact, for papers by Ahmad Shariftabrizi Breakdown of academic impact, for papers by Domenico Sergi Breakdown of academic impact, for papers by Rafał Stec Breakdown of academic impact, for papers by Yingying Hao Breakdown of academic impact, for papers by Qiongrong Chen Breakdown of academic impact, for papers by Fei Lian Breakdown of academic impact, for papers by Alaa Abduljabbar Breakdown of academic impact, for papers by Philip E. Lammers Breakdown of academic impact, for papers by Morikazu Miyamoto
Rankless by CCL
2026